409 related articles for article (PubMed ID: 22851684)
1. Use of troponin to diagnose periprocedural myocardial infarction: effect on composite endpoints in the British Bifurcation Coronary Study (BBC ONE).
Cockburn J; Behan M; de Belder A; Clayton T; Stables R; Oldroyd K; Curzen N; Hildick-Smith D
Heart; 2012 Oct; 98(19):1431-5. PubMed ID: 22851684
[TBL] [Abstract][Full Text] [Related]
2. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
[TBL] [Abstract][Full Text] [Related]
3. Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.
Chen SL; Zhang JJ; Ye F; Tian NL; Sheiban I; Jepson N; Paiboon C; Sansoto T; Kwan TW; Wen SY; Wang HC; Jiang TM; Wang Y; Chen LL; Qiu CG; Zhang YJ; Chen MX; De Maria A
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():696-705. PubMed ID: 25631678
[TBL] [Abstract][Full Text] [Related]
4. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.
Lim CC; van Gaal WJ; Testa L; Cuculi F; Arnold JR; Karamitsos T; Francis JM; Petersen SE; Digby JE; Westaby S; Antoniades C; Kharbanda RK; Burrell LM; Neubauer S; Banning AP
J Am Coll Cardiol; 2011 Feb; 57(6):653-61. PubMed ID: 21292125
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
7. Varying definitions for periprocedural myocardial infarction alter event rates and prognostic implications.
Idris H; Lo S; Shugman IM; Saad Y; Hopkins AP; Mussap C; Leung D; Thomas L; Juergens CP; French JK
J Am Heart Assoc; 2014 Oct; 3(6):e001086. PubMed ID: 25359403
[TBL] [Abstract][Full Text] [Related]
8. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
[TBL] [Abstract][Full Text] [Related]
9. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin converting enzyme inhibitors on periprocedural myocardial infarction in patients with metabolic syndrome.
Ozcan OU; Ustun EE; Gulec S; Gerede DM; Goksuluk H; Vurgun VK; Kaya CT; Erol C
Cardiol J; 2015; 22(3):323-9. PubMed ID: 25563711
[TBL] [Abstract][Full Text] [Related]
11. Periprocedural myocardial infarction is not associated with an increased risk of long-term cardiac mortality after coronary bifurcation stenting.
Song PS; Song YB; Yang JH; Kang GH; Hahn JY; Choi SH; Choi JH; Lee SH; Jang Y; Yoon JH; Tahk SJ; Seung KB; Park SJ; Gwon HC
Int J Cardiol; 2013 Aug; 167(4):1251-6. PubMed ID: 22494861
[TBL] [Abstract][Full Text] [Related]
12. Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.
Toso A; Leoncini M; Maioli M; Gallopin M; Tedeschi D; Amato M; Bellandi F
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):318-21. PubMed ID: 21045713
[TBL] [Abstract][Full Text] [Related]
13. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow).
Stone GW; Maehara A; Muller JE; Rizik DG; Shunk KA; Ben-Yehuda O; Genereux P; Dressler O; Parvataneni R; Madden S; Shah P; Brilakis ES; Kini AS;
JACC Cardiovasc Interv; 2015 Jun; 8(7):927-36. PubMed ID: 26003018
[TBL] [Abstract][Full Text] [Related]
14. Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents.
Popma JJ; Mauri L; O'Shaughnessy C; Overlie P; McLaurin B; Almonacid A; Kirtane A; Leon MB
Circ Cardiovasc Interv; 2009 Apr; 2(2):133-9. PubMed ID: 20031706
[TBL] [Abstract][Full Text] [Related]
15. Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions.
Sheiban I; Infantino VA; Colombo F; Bollati M; Omedè P; Moretti C; Sciuto F; Siliquini R; Chiadò S; Trevi GP; Biondi-Zoccai G
Catheter Cardiovasc Interv; 2009 Aug; 74(2):313-20. PubMed ID: 19496110
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
[TBL] [Abstract][Full Text] [Related]
17. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
[TBL] [Abstract][Full Text] [Related]
18. The three year follow-up of the randomised "all-comers" trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS).
Wykrzykowska J; Serruys P; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; Di Mario C; Van Geuns RJ; Van Es GA; Juni P; Windecker S
EuroIntervention; 2011 Nov; 7(7):789-95. PubMed ID: 22027687
[TBL] [Abstract][Full Text] [Related]
19. Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents.
Tandjung K; Basalus MW; Muurman E; Louwerenburg HW; van Houwelingen KG; Stoel MG; de Man FH; Jansen H; Huisman J; Linssen GC; Droste HT; Nienhuis MB; von Birgelen C
Catheter Cardiovasc Interv; 2012 Oct; 80(4):524-30. PubMed ID: 22109857
[TBL] [Abstract][Full Text] [Related]
20. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
